secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2023-05-23T23:59:59+00:00
Accession:  0001005286-23-000087
Event type: debt
Sentiment:  positive
Materiality: 0.85
Item codes: 1.01, 1.02, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore Biomedical secures $150M financing from Alcon; repays existing term loan, extends HA supply deal
--------------------------------------------------------------------------------

- New $140M term loan from Alcon at 10% interest, PIK for first 3 years, matures May 2029.
- $10M equipment sale-leaseback with Alcon for HA fermentation assets; lease expires May 2033.
- Existing Goldman Sachs term loan fully repaid; BMO ABL amended with waiver of all current defaults.
- Amended supply agreement with Alcon extends to Dec 2033, increases expected HA product volumes.
- Company continues evaluation of strategic alternatives to maximize shareholder value.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528623000087/0001005286-23-000087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528623000087/lndc-20230522.htm
  HTML page:      https://secwatch.observer/filing/0001005286-23-000087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer